New hope for Tough-to-Treat blood cancer: Head-to-Head drug battle
Disease control
Ongoing
This study compares two different three-drug combinations for people with multiple myeloma that has returned or stopped responding to previous treatments. It aims to see which combination works better at controlling the cancer, is safer, and improves patients' quality of life. Th…
Phase: PHASE3 • Sponsor: European Myeloma Network B.V. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC